Faculty Research
Prachi Arora
Assistant Professor of Pharmacy Practice
317-940-9417, parora@butler.edu
I am a health outcomes researcher whose work focuses on assessing the role of comparative effectiveness research on clinical decision making, designing cost-effectiveness models and evaluating the impact of health policies (e.g. Affordable Care Act) on healthcare coverage and utilization. I have hands-on experience with secondary database such as CMS, MEPS, NSFG, NSDUH and statistical software like SAS and STATA.
Caleb Class
Assistant Professor of Pharmaceutical Sciences
317-940-9831, cclass@butler.edu
Understanding genomic data through bioinformatics can help us solve some of the most complicated medical problems of our time. Class’s research involves the data mining and analysis of metabolomic, genomic, and other data to identify potential cancer treatment strategies. Research projects also include the development of new bioinformatics software that allows any researcher to more easily understand complicated biological data.
Nandita G. Das, PhD, RPh
Professor of Pharmaceutical Sciences (Pharmaceutics)
317-940-9015, ndas@butler.edu
Dr. Nandita Das’ research involves targeted delivery of siRNA against neurodegenerative diseases such as Alzheimer’s and Huntington’s disease, and modulation of Multi-Drug Resistance (Pgp and MRP) in cancer. Specifically, Dr. Das’ research projects involve fabrication and characterization of lipospheres and liposomes for nanomedicine applications. View Dr. Das’ Nanomedicine Research Page.
Sudip K. Das, PhD
Professor of Pharmaceutical Sciences (Pharmaceutics)
317-940-9134, sdas@butler.edu
Dr. Sudip Das’ research involves nanotechnology approaches in targeted delivery of siRNA and small molecule drugs for the treatment of cancer. Specifically, Dr. Sudip Das’ research projects involve fabrication and characterization of polymer nanoparticles for nanomedicine applications. View Dr. Sudip Das’ Nanomedicine Research Page.
Alexandre M. Erkine, PhD
Professor of Pharmaceutical Sciences (Bioinformatics & Mol. Biology)
317-940-8569, aerkine@butler.edu
Bioinformatics including machine learning combined with methods of modern molecular biology is a powerful tool. The combination of these methods allows us to take a fresh look at the fundamental problems of biochemistry and pharmacology. View details of Dr. Erkine’s publications.
Visit Dr. Erkine’s research site
Hala Fadda, PhD, MRPharmS
Associate Professor of Pharmaceutical Sciences (Pharmaceutics)
317- 940-8574, hfadda@butler.edu
Dr. Fadda’s research focuses on bridging the physical and biological sciences in the field of pharmaceutics to gain a better understanding of drug bioavailability and some of the reasons behind the intra- and inter-individual variability in drug exposure. Focus on gastrointestinal physiology to set up an in vitro drug release model that better simulates the diverse and dynamic nature of our guts in different patient populations.
W. Conrad Hong, PhD
Assistant Professor of Pharmaceutical Sciences (Pharmacology)
317-940-9580, chong@butler.edu
Dr. Hong’s research focuses on the investigation of signaling mechanisms of dopamine in the brain, particularly the dopamine transporter (DAT), a membrane carrier uniquely expressed on dopamine neurons. DAT and its close homologs (the serotonin transporter and norepinephrine transporter) are important targets of therapeutic agents such as antidepressants and ADHD medications, and abused psychostimulants cocaine and methamphetamine.
C. Patience Masamha, PhD
Assistant Professor of Pharmaceutical Sciences (Pharmacology)
317-940-6428, cmasamha@butler.edu
Dr. Masamha’s research is focused on understanding the mechanisms that drive oncogenesis and the development of novel, targeted anti-cancer RNA based therapeutics. The Masamha lab uses second and third generation sequencing technology and bioinformatics to identify novel cancer-causing gene transcripts that can be used as cancer biomarkers and potential drug targets.